Compliance Rate
Compliance Rate
50.0%
Compliant submissions
3
Incompliant submissions
3
Total trials
6
My Organizations' Clinical Trials
Showing 625 of 1457 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 07/01/30
Due: 07/01/31
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 07/31/17
Due: 07/31/18
Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins
Phase: N/A
Priority: Normal
Start: 08/01/20
End: 07/14/25
Due: 07/14/26
Phase: N/A
Priority: Normal
Start: 09/30/21
End: 10/04/23
Due: 10/04/24
Phase: N/A
Priority: Normal
Start: 10/17/19
End: 06/26/23
Due: 06/26/24
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 03/31/19
Due: 03/31/20
Phase: N/A
Priority: Normal
Start: 11/07/18
End: 09/20/22
Due: 09/20/23
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 04/30/04
End: 11/30/08
Due: 11/30/09
Phase: N/A
Priority: Normal
Start: 12/30/18
End: 12/30/18
Due: 12/30/19
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 09/30/04
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 05/25/17
End: 02/12/19
Due: 02/12/20
Phase: N/A
Priority: Normal
Start: 11/09/16
End: 02/17/21
Due: 02/17/22
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 03/01/18
Due: 03/01/19
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 03/25/24
End: 10/03/24
Due: 10/03/25
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 02/28/13
Due: 02/28/14
Phase: N/A
Priority: Normal
Start: 11/24/10
End: 10/22/18
Due: 10/22/19
Phase: N/A
Priority: Normal
Start: 02/28/06
End: 03/31/06
Due: 03/31/07
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 12/31/25
Due: 12/31/26